Nuclear morphometry and molecular biomarkers of actinic keratosis, sun-damaged, and nonexposed skin.

Computer-assisted image analysis is useful for quantifying the histologic and molecular changes of sun-induced squamous cell carcinoma progression. We used the CAS 200 image analysis system to measure nuclear morphometric parameters, p53 expression, and proliferation markers in actinic keratosis (AK), sun-exposed, and normal skin in 51 patients. Nuclear morphometry revealed significant increases in nuclear absorbance, irregularity of nuclear shape, and nuclear size in AK compared with normal and sun-damaged skin. These parameters showed significantly greater variability in AK nuclei. Argyrophyllic nucleolar organizer area and number were also significantly greater in AK compared with sun-damaged skin and normal skin. Ki67 and p53 expressions were both increased in sun-damaged skin relative to normal and greater still in AK. These data are evidence that sun damage induces proliferation and p53 abnormalities before the appearance of nuclear abnormalities and their associated DNA instability. Following these changes during a skin cancer chemopreventative trial can then help assess the efficacy of the agent and help determine where in the progression of neoplastic changes it exerts its biological effects.

[1]  D. McConkey,et al.  Temporal events in skin injury and the early adaptive responses in ultraviolet-irradiated mouse skin. , 2000, The American journal of pathology.

[2]  J W Bacus,et al.  Optical microscope system for standardized cell measurements and analyses. , 1987, Applied optics.

[3]  D. Alberts,et al.  Relationship of p53 mutations to epidermal cell proliferation and apoptosis in human UV-induced skin carcinogenesis. , 1999, Neoplasia.

[4]  B. Vogelstein,et al.  The relationship of quantitative nuclear morphology to molecular genetic alterations in the adenoma-carcinoma sequence of the large bowel. , 1992, The American journal of pathology.

[5]  P. Autier,et al.  Intermediate-effect biomarkers in prevention of skin cancer. , 2001, IARC scientific publications.

[6]  R. Tarone,et al.  Frequent clones of p53-mutated keratinocytes in normal human skin. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[7]  T. Jacks,et al.  Sunburn and p53 in the onset of skin cancer , 1994, Nature.

[8]  P H Bartels,et al.  Nuclear morphometry in solar keratosis. , 1998, Analytical and quantitative cytology and histology.

[9]  P. Jeannesson,et al.  Improvement in the staining and in the visualization of the argyrophilic proteins of the nucleolar organizer region at the optical level , 2005, The Histochemical Journal.

[10]  F. Pontén,et al.  Human epidermal cancer and accompanying precursors have identical p53 mutations different from p53 mutations in adjacent areas of clonally expanded non-neoplastic keratinocytes. , 1996, Oncogene.

[11]  S. Syrjänen,et al.  Expression of cell-cycle proteins p53, p21 (WAF-1), PCNA and Ki-67 in benign, premalignant and malignant skin lesions with implicated HPV involvement. , 1999, Acta dermato-venereologica.

[12]  J. Bartek,et al.  Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies. , 1991, Oncogene.

[13]  E. Healy,et al.  Dissociation of erythema and p53 protein expression in human skin following UVB irradiation, and induction of p53 protein and mRNA following application of skin irritants. , 1994, The Journal of investigative dermatology.

[14]  M Aickin,et al.  Expression of p53 protein in actinic keratosis, adjacent, normal-appearing, and non-sun-exposed human skin. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[15]  D. Alberts,et al.  Analysis of the p53 gene in human precancerous actinic keratosis lesions and squamous cell cancers. , 1994, Cancer letters.

[16]  N. Basset-Seguin,et al.  TP53 tumor suppressor gene and skin carcinogenesis. , 1994, The Journal of investigative dermatology.

[17]  D. English,et al.  UV and skin cancer: specific p53 gene mutation in normal skin as a biologically relevant exposure measurement. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[18]  N. Flanagan,et al.  Low frequency of genetic change in p53 immunopositive clones in human epidermis. , 1999, The Journal of investigative dermatology.

[19]  N. S. Mcnutt,et al.  Abnormalities of p53 protein expression in cutaneous disorders. , 1994, Archives of dermatology.

[20]  James Ranger-Moore,et al.  Karyometry of nuclei from actinic keratosis and squamous cell cancer of the skin. , 2003, Analytical and quantitative cytology and histology.

[21]  G. Rennie,et al.  MALIGNANT TRANSFORMATION OF SOLAR KERATOSES TO SQUAMOUS CELL CARCINOMA , 1988, The Lancet.

[22]  K. Vousden,et al.  Minireviewp 53 : Death Star able to induce the defensive p 53 response to oncogene , 2000 .

[23]  C. Cockerell,et al.  Histopathology of incipient intraepidermal squamous cell carcinoma ("actinic keratosis"). , 2000, Journal of the American Academy of Dermatology.

[24]  D. Brash,et al.  Skin precancer. , 1998, Cancer surveys.

[25]  Jean-Paul Ortonne,et al.  From actinic keratosis to squamous cell carcinoma , 2002, The British journal of dermatology.

[26]  D. Alberts,et al.  Chemoprevention of human actinic keratoses by topical 2-(difluoromethyl)-dl-ornithine. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[27]  J. Dufer,et al.  Clinical applications of image cytometry to human tumour analysis. , 2000, Histology and histopathology.

[28]  Gundula Schaumburg-Lever,et al.  Histopathology of the skin , 1975 .

[29]  C. Cohen.  Image cytometric analysis in pathology. , 1996, Human pathology.

[30]  Jean Kanitakis,et al.  Comparative nuclear morphometric analysis of aggressive and non-aggressive squamous cell carcinomas of the skin. , 1997, Acta dermato-venereologica.

[31]  D. Cox,et al.  An Analysis of Transformations , 1964 .

[32]  F. Collins,et al.  Mutations in the p53 gene occur in diverse human tumour types , 1989, Nature.

[33]  P. Bartels,et al.  Measurement of chemopreventive efficacy in skin biopsies. , 2001, Analytical and quantitative cytology and histology.

[34]  M. Kripke,et al.  p53 protects against skin cancer induction by UV-B radiation , 1999, Oncogene.

[35]  D. Alberts,et al.  Modulation of biologic endpoints by topical difluoromethylornithine (DFMO), in subjects at high-risk for nonmelanoma skin cancer. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[36]  L. True,et al.  Morphometric applications in anatomic pathology. , 1996, Human pathology.

[37]  M. Ueda,et al.  Cyclin D and retinoblastoma gene product expression in actinic keratosis and cutaneous squamous cell carcinoma in relation to p53 expression , 1995, Journal of cutaneous pathology.

[38]  D. Mcgibbon,et al.  Aneuploidy in Bowen's disease , 1986, The British journal of dermatology.

[39]  C. McLaren,et al.  Chemoprevention of nonmelanoma skin cancer: experience with a polyphenol from green tea. , 2002, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[40]  D. Gisselsson,et al.  Abnormal nuclear shape in solid tumors reflects mitotic instability. , 2001, The American journal of pathology.

[41]  C. Boone,et al.  Biomarker end-points in cancer chemoprevention trials. , 1997, IARC scientific publications.

[42]  Yogendra P. Chaubey.  Resampling-Based Multiple Testing: Examples and Methods for p-Value Adjustment , 1993 .

[43]  S. Biesterfeld,et al.  Aneuploidy in actinic keratosis and Bowen's disease—increased risk for invasive squamous cell carcinoma? , 1995, The British journal of dermatology.

[44]  A. Offidani,et al.  Advances in the understanding of malignant transformation of keratinocytes: an immunohistochemical study. , 1998, Journal of the European Academy of Dermatology and Venereology : JEADV.

[45]  C. Campbell,et al.  p53 mutations are common and early events that precede tumor invasion in squamous cell neoplasia of the skin. , 1993, The Journal of investigative dermatology.

[46]  J. Rees,et al.  Genetic change in actinic keratoses. , 1996, Oncogene.